share_log

深圳价值在线咨询顾问有限公司关于杭州奥泰生物技术股份有限公司2022年限制性股票激励计划预留授予第一个归属期符合归属条件事项之独立财务顾问报告

Shenzhen Valuation Online Consulting Limited's independent financial advisor report on Hangzhou Otech Biotechnology Co., Ltd.'s 2022 restricted stock incentive plan for the first vesting period reserved for the fulfillment of attribution conditions.

SZSI ·  Jul 19
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more